• CATEGORIES
    • All Categories
    • Antiques
    • Art
    • Automotive
    • Baby
    • Beauty & Fragrances
    • Books & Magazines
    • Business & Industrial
    • Cameras & Photo
    • Cell Phones, PDAs & Accessories
    • Clothing & Shoes
    • Collectibles
    • Computers & Networking
    • Crafts
    • Electronics
    • Entertainment Memorabilia
    • Flowers & Gifts
    • Glass & Pottery
    • Health & Personal Care
    • Home & Garden
    • Jewelry & Watches
    • Misc
    • Movies & DVDs
    • Music
    • Office Supplies
    • Real Estate
    • Services
    • Sex Stuff
    • Sports & Outdoors
    • Sports Memorabilia
    • Tools & Hardware
    • Toys, Games & Hobbies
    • Video Games
  • COMMUNITY
  • FAQ
  • SELL
  • US
    • US
    • UK
    • AU
  • Cart
eCrater
  • Sign Up
  • Login
  • Home >
  • All Categories >
  • Health & Personal Care(77125)
$10.00 Add to Cart

Anti-CD22 (clone 10F4v3)-Mc-VC-PABC-MMAE ADC

Anti-CD22 (clone 10F4v3)-Mc-VC-PABC-MMAE ADC

More than 10 available

Details

Shipping: US-Mainland: free (more destinations)

Condition: Brand new

*The store has not been updated recently. You may want to contact the merchant to confirm the availability of the product.

Tweet    
  • Description
This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4v3) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAE binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death. http://www.creative-biolabs.com/adc/target-cd22-10.htm
... [Full Description]

Title of Image

Seller Information

Seller

creativebiolabs
  • Contact Seller
  • No Feedback Yet
‹ ›
View Store

Location

  • US, Shirley, NY

Payment

  • Cash On delivery
  • © 2026
  • ·
  • eCRATER
  • ·
  • Get your free online store
Last Updated: 28 Jul 2023 02:28:23 PDT
  • about
  • ·
  • terms
  • ·
  • privacy
  • ·
  • dmca
  • ·
  • contact
  • ·
  • news
Follow Us